Search by Drug Name or NDC
NDC 62135-0308-28 Ciprofloxacin 250 mg/1 Details
Ciprofloxacin 250 mg/1
Ciprofloxacin is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC.. The primary component is CIPROFLOXACIN HYDROCHLORIDE.
MedlinePlus Drug Summary
Ciprofloxacin is used to treat or prevent certain infections caused by bacteria such as pneumonia; gonorrhea (a sexually transmitted disease); typhoid fever (a serious infection that is common in developing countries); infectious diarrhea (infections that cause severe diarrhea); and infections of the skin, bone, joint, abdomen (stomach area), and prostate (male reproductive gland), Ciprofloxacin is also used to treat or prevent plague (a serious infection that may be spread on purpose as part of a bioterror attack) and inhalation anthrax (a serious infection that may be spread by anthrax germs in the air on purpose as part of a bioterror attack). Ciprofloxacin may also be used to treat bronchitis, sinus infections, or urinary tract infections but should not be used for bronchitis and sinus infections, or certain types of urinary tract infections if there are other treatment options. Ciprofloxacin extended-release (long-acting) tablets are used to treat kidney and urinary tract infections; however, some types of urinary tract infections should only be treated with ciprofloxacin extended release tablets if no other treatment options are available. Ciprofloxacin is in a class of antibiotics called fluoroquinolones. It works by killing bacteria that cause infections. Antibiotics such as ciprofloxacin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 62135-0308-28Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ciprofloxacin
Product Information
NDC | 62135-0308 |
---|---|
Product ID | 62135-308_f2a0db9f-16a8-1603-e053-2995a90a79a3 |
Associated GPIs | 05000020100310 |
GCN Sequence Number | 009509 |
GCN Sequence Number Description | ciprofloxacin HCl TABLET 250 MG ORAL |
HIC3 | W1Q |
HIC3 Description | QUINOLONE ANTIBIOTICS |
GCN | 47050 |
HICL Sequence Number | 004124 |
HICL Sequence Number Description | CIPROFLOXACIN HCL |
Brand/Generic | Generic |
Proprietary Name | Ciprofloxacin |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Ciprofloxacin hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/1 |
Substance Name | CIPROFLOXACIN HYDROCHLORIDE |
Labeler Name | Chartwell RX, LLC. |
Pharmaceutical Class | Quinolone Antimicrobial [EPC], Quinolones [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA076896 |
Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0308-28 (62135030828)
NDC Package Code | 62135-308-28 |
---|---|
Billing NDC | 62135030828 |
Package | 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (62135-308-28) |
Marketing Start Date | 2021-04-13 |
NDC Exclude Flag | N |
Pricing Information | N/A |